Reversal effects of components from the fruits of Illicium simonsii on human adriamycin-resistant MCF-7 and 5-fluorouracil-resistant Bel7402 cells

Phytotherapy Research

Volumn 26, Issue 4, 2012, Pages 562-567

  Wei, Dan Dan ^a   Wang, Jun Song ^a   Kong, Ling Yi ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Bel7402 5 FU; Illicium simonsii; MCF 7 ADR; multidrug resistance (MDR); multidrug resistance associated protein (MRP); P glycoprotein (Pgp)

Indexed keywords

1,2,3 TRIMETHOXYBENZENE; 1ALPHA HYDROXY 3 DEOXY PSEUDOANISATIN; 1H INDOLE 3 CARBOXALDEHYDE; 2 (4 HYDROXY 3 METHOXYPHENYL) 3 (2 HYDROXY 5 METHOXYPHENYL) 3 OXO 1 PROPANOL; 2 HYDROXY 4 (2 PROPENYL)PHENYL BETA DEXTRO GLUCOPYRANOSIDE; 3 HYDROXY BETA 4 BIS(METHYLENE)CYCLOHEXANEETHANOL; 3,4 DIHYDROXYBENZOIC ACID ETHYL ESTER; 3,4' DIHYDROXY 3' METHOXYPROPIOPHENONE; 4 HYDROXYBENZALDEHYDE; 4 HYDROXYBENZOIC ACID; 4 MENTH 1 ENE 3,8 DIOL; 6 PSEUDOMAJUCIN; 8 MENTHENE 1,2 DIOL; 8ALPHA HYDROXY 10 DEOXYCYCLOMERRILLIANOLIDE; ANISATIN; DOXORUBICIN; FLUOROURACIL; GLYCOPROTEIN P; ILLICIUM SIMONSII EXTRACT; MULTIDRUG RESISTANCE PROTEIN; NEOPHASEIC ACID; OLIGANDRUMIN B; OLIGANDRUMIN D; PACLITAXEL; PLANT EXTRACT; PROTOCATECHUIC ACID; SESQUITERPENE LACTONE DERIVATIVE; SHIKIMIC ACID; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERANISATIN D;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMOSENSITIVITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG SCREENING; DRUG STRUCTURE; FRUIT; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYDROPHILICITY; IC 50; ILLICIUM; ILLICIUM SIMONSII; IN VITRO STUDY; LIVER CARCINOMA; MULTIDRUG RESISTANCE; PRINCIPAL COMPONENT ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STOMACH CANCER; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FLUOROURACIL; FRUIT; HELA CELLS; HEP G2 CELLS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; ILLICIUM; INHIBITORY CONCENTRATION 50; P-GLYCOPROTEINS; PLANT EXTRACTS; PRINCIPAL COMPONENT ANALYSIS; STRUCTURE-ACTIVITY RELATIONSHIP;

ILLICIUM;

EID: 84859588762     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3599     Document Type: Article

References (32)

1. Arsuaga JM, Lõpez-Muñoz MJ, Sotto A,. 2010. Correlation between retention and adsorption of phenolic compounds in nanofiltration membranes. Desalination 250: 829-832.
2. Barnes KM, Dickstein B, Cutler GB, Jr, Fojo T, Bates SE,. 1996. Steroid transport, accumulation and antagonism of P-glycoprotein in multidrug-resistant cells. Biochemistry 35: 4820-4827.
3. Boumendjel A, Pietro AD, Dumontet C, Barron D,. 2002. Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance. Med Res Rev 22: 512-529.
4. Choi CH,. 2005. ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. Cancer Cell Int 5: 30.
5. Dei S, Teodori E, Garnier-Suillerot A, et al. 2001. Structure-activity relationships and optimisation of the selective MDR modulator 2-(3,4-dimethoxyphenyl)-5-(9-fluorenylamino)-2-(methylethyl) pentanenitrile and its N-methyl derivative. Bioorg Med Chem 9: 2673-2682.
6. Efferth T, Davey M, Olbrich A, Rücker G, Gebhart E, Davey R,. 2002. Activity of drugs from Traditional Chinese Medicine toward sensitive and MDR1- or MRP1- overexpressing multidrug resistance human CCRF-CEM leukemia cells. Blood Cell Mol Dis 28: 160-168.
7. Fardel O, Lecureur V, Guillouzo A,. 1996. The P-Glycoprotein Multidrug Transporter. Gen Pharmacol 27: 1283-1291.
8. Fetisova EK, Avetisyan AV, Izyumov DS, Korotetskaya MV, Chernyak BV, Skulachev VP,. 2010. Mitochondria-targeted antioxidant SKQR1 selectively protects MDR (Pgp 170)-negative cells against oxidative stress. FEBS Lett 584: 562-566.
9. Filipits M,. 2004. Mechanisms of cancer: multidrug resistance. Drug Discov Today 1: 229-234
10. Ford JM, Bruggemann EP, Pastan I, Gottesman MM, Hait WN,. 1990. Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines. Cancer Res 50: 1748-1756.
11. Gottesman MM,. 2002. Mechanisms of cancer drug resistance. Annu Rev Med 53: 615-627.
12. Higgins CF,. 2007. Multiple molecular mechanisms for multidrug resistance transports. Nature 446: 749-757.
13. Huang M, Liu GT,. 1999. The study of innate drug resistance of human hepatocellular carcinoma Bel7402 cell line. Cancer Lett 135: 97-105.
14. Jin J, Huang M, Wei HL, Liu GT,. 2002. Mechanism of 5-fluorouracil required resistance in human hepatocellular carcinoma cell line Bel7402. World J Gastroenterol 8: 1029-1034.
15. Kouno I, Iwamoto C, Kameda Y, Tanaka T, Yang CS,. 1994. A new triphenyl-type neolignan and a biphenylneolignan from the bark of Illicium simonsii. Chem Pharm Bull 42: 112-114.
16. Lin Q,. 2002. Medicinal plants resources on genus Illicium. Chin Tradit Herbal Drugs 33: 654-657.
17. Liu LF, Desai SD, Li TK, Mao Y, Sun M, Sim SP,. 2000. Mechanisms of action of Camptothecin. Ann N Y Acad Sci 992: 1-10.
18. 3 compounds with molecular diversity from the roots of Illicium oligandrum. Phytochemistry 72: 115-125.
19. Matteis CID, Simpson DA, Doughty SW, Euerby MR, Shaw PN, Barrett DA,. 2010. Chromatographic retention behaviour of n-alkylbenzenes and pentylbenzene structural isomers on porous graphitic carbon and octadecyl-bonded silica studied using molecular modelling and QSRR. J Chromatogr A 1217: 6987-6993.
20. Moriyama M, Huang JM, Yang CS, et al. 2007. Structure and neurotrophic activity of novel sesqui-neolignans from the pericarps of Illicium fargesii. Tetrahedron 63: 4243-4249.
21. Pajeva IK, Wiese M,. 2001. Human P-glycoprotein pseudoreceptor modeling: 3D-QSAR study on thioxanthene type multidrug resistance modulators. Quant Struct-Act Relat 20: 130-138.
22. Pearce HL, Safa AR, Bach NJ, Winter MA, Cirtain MC, Beck WT,. 1989. Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance. Proc Natl Acad Sci USA 86: 5128-5132.
23. Peer D, Margalit R,. 2006. Fluoxetine and reversal of multidrug resistance. Cancer Lett 237: 180-187.
24. Shang XY, Guo MR, Zhao CW, Li S,. 2008. Studies on chemical constituents of Illicium simonsii. Chin J Chin Mater Med 33: 2490-2492.
25. Stouch TR, Gudmundsson O,. 2002. Progress in understanding the structure-activity relationships of P-glycoprotein. Adv Drug Deliv Rev 54: 315-328.
26. 3 compounds and a highly oxygenated seco-Prezizaane type sesquiterpene from stem bark of Illicium oligandrum. J Nat Prod 72: 1017-1021.
27. Walter RB, Pirga JL, Cronk MR, Mayer S, Appelbaum FR, Banker DE,. 2005. PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanism. Blood 106: 3584-3593.
28. Wu JH, Li X, Cheng WD, Xie QJ, Liu YQ, Zhao CY,. 2009. Quantitative structure activity relationship (QSAR) approach to multiple drug resistance (MDR) modulators based on combined hybrid system. QSAR Comb Sci 9: 969-978.
29. 3 compounds from the fruits of Illicium simonsii. J Asian Nat Prod Res 11: 1056-1061.
30. Yang CS, Wang JL, Zhang ZL, Kouno I,. 1991. Studies on the toxic constituents of Illicium simonsii Maxim. Acta Pharm Sin 26: 128-131.
31. Yu XQ, Xue CL, Wang GJ, Zhou SF,. 2007. Multidrug resistance associated proteins as ceterming factors of pharmacokinetics and pharmacodynamics of drug. Curr Drug Metab 8: 787-802.
32. Zhu Q, Tang CP, Ke CQ, Wang W, Zhang HY, Ye Y,. 2009. Sesquiterpenoids and phenylpropanoids from pericarps of Illicium oligandrum. J Nat Prod 72: 238-242.